NEPH Stock Overview
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$2.05|
|52 Week High||US$11.67|
|52 Week Low||US$2.00|
|1 Month Change||-54.65%|
|3 Month Change||-58.16%|
|1 Year Change||-73.20%|
|3 Year Change||-62.66%|
|5 Year Change||-13.19%|
|Change since IPO||-99.80%|
Recent News & Updates
|NEPH||US Consumer Durables||US Market|
Return vs Industry: NEPH underperformed the US Consumer Durables industry which returned -27.8% over the past year.
Return vs Market: NEPH underperformed the US Market which returned -10.4% over the past year.
|NEPH Average Weekly Movement||14.3%|
|Consumer Durables Industry Average Movement||7.6%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||16.7%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: NEPH is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: NEPH's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
Nephros Fundamentals Summary
|NEPH fundamental statistics|
Is NEPH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NEPH income statement (TTM)|
|Cost of Revenue||US$4.67m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.54|
|Net Profit Margin||-56.23%|
How did NEPH perform over the long term?See historical performance and comparison
Is Nephros undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate NEPH's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate NEPH's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: NEPH is unprofitable, so we can't compare its PE Ratio to the US Consumer Durables industry average.
PE vs Market: NEPH is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NEPH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NEPH is overvalued based on its PB Ratio (2.1x) compared to the US Consumer Durables industry average (1.3x).
How is Nephros forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NEPH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NEPH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NEPH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NEPH's revenue (25% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: NEPH's revenue (25% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NEPH's Return on Equity is forecast to be high in 3 years time
How has Nephros performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NEPH is currently unprofitable.
Growing Profit Margin: NEPH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NEPH is unprofitable, and losses have increased over the past 5 years at a rate of 17.6% per year.
Accelerating Growth: Unable to compare NEPH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NEPH is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Durables industry (45.1%).
Return on Equity
High ROE: NEPH has a negative Return on Equity (-39.52%), as it is currently unprofitable.
How is Nephros's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: NEPH's short term assets ($11.7M) exceed its short term liabilities ($1.7M).
Long Term Liabilities: NEPH's short term assets ($11.7M) exceed its long term liabilities ($378.0K).
Debt to Equity History and Analysis
Debt Level: NEPH has more cash than its total debt.
Reducing Debt: NEPH's debt to equity ratio has reduced from 63.2% to 2.1% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NEPH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NEPH has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 10.9% each year.
What is Nephros's current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NEPH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NEPH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NEPH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NEPH's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NEPH has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Andy Astor (64 yo)
Mr. Andrew Astor, also known as Andy, serves as Chief Financial Officer at Nephros, Inc. since January 28, 2021. He has been Chief Executive Officer, President and Director of Nephros, Inc. since August 24...
CEO Compensation Analysis
Compensation vs Market: Andy's total compensation ($USD545.72K) is about average for companies of similar size in the US market ($USD771.12K).
Compensation vs Earnings: Andy's compensation has been consistent with company performance over the past year.
Experienced Management: NEPH's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Experienced Board: NEPH's board of directors are considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.6%.
Nephros, Inc.'s employee growth, exchange listings and data sources
- Name: Nephros, Inc.
- Ticker: NEPH
- Exchange: NasdaqCM
- Founded: 1997
- Industry: Household Appliances
- Sector: Consumer Durables
- Implied Market Cap: US$21.154m
- Shares outstanding: 10.32m
- Website: https://www.nephros.com
Number of Employees
- Nephros, Inc.
- 380 Lackawanna Place
- South Orange
- New Jersey
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/14 00:00|
|End of Day Share Price||2022/05/13 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.